Publications

The anti-obesity drug revolution: a booming market

Article published in allnews on October 4, 2024

“Innovation is the key to success for pharmaceutical companies, whose leadership position can waver at any moment.”

At a time when obesity has become a global priority, pharmaceutical companies are racing to develop innovative solutions. Leaders such as Eli Lilly and Novo Nordisk currently dominate, but competition is intensifying and new molecules could change the game.

Read the commentary by Stéphanie Rheinboldt, Senior Equity Advisor, published in Allnews on October 4, 2024, in French : La course aux médicaments anti-obésité | Allnews

October 04, 2024

Publications

CIO Letter - October 2026

Rate noise, solid fundamentals

October 13, 2026

Publications

CIO Letter - September 2026

When Higher Rates Become a Policy Risk

September 16, 2026

Publications

Letter From the CIO - August 2026

Good Companies, Good Investments?

August 18, 2026